About this trial
The study wants to evaluate the performance of this EM guide in comparison to a traditional IM guide.
75 patients will be included in the extramedullary group (to be compared with a corresponding previous group of 75 patients treated with intramedullary guide).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Male or female ≥ 18 years old
Indication to primary TKA, for any diagnosis operated with EM or IM guides
Signature of the informed consent (only for prospective cohort)
Been operated upon between January 2021 and September 2025 (only for retrospective cohort)
Disqualifiers
Revision surgery of knee arthroplasty
Patients with malignant diseases (at the time of surgery)
Patients with proven or suspect infections (at the time of surgery)
Pregnancy end/or lactating (auto declaration)
Trial population
The study shall include a total of 150 patients: 75 will be included in the extramedullary group, to be compared with a corresponding previous group of 75 patients treated with intramedullary guide. Patients meeting the inclusion criteria (mentioned below) will be recruited separately by each participating institution. Patient enrolled in the retrospective analysis have been operated upon between January 2021 and September 2025.
Trial design
Case-control
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Anterior Cortex Stylus
Radiographic angle at 3 moth post-op of the femoral component in TKA in an Anterior Cortex Stylus (retro-prospective collected series) compared to intramedullary guide (previous group of patients)
Secondary outcomes
Results across study centres
Radiographic angles compared between the centres (at pre-op, surgery and 3 month post-op)
Adverse Events to determinate Instrument safety
Number of: adverse events, adverse device effects, serious adverse events and serious adverse device effects
Sponsors and contacts
Click on the lead sponsor to view all of their trials.